#FDA 2/4

top of page

CHEARS

Home
About
Activities
Resources
Your Profile
Registration
Active Courses
- Introduction to AI
Contact
More

Use tab to navigate through the menu items.

$Xpovio (selinexor) Approved for the Treatment of Patients with Relapsed or Refractory Multiple Myelo$

Jul 9, 2019

Xpovio (selinexor) Approved for the Treatment of Patients with Relapsed or Refractory Multiple Myelo

Not to Use Kratom NC’s Products

Jun 26, 2019

Not to Use Kratom NC’s Products

May 4, 2019

FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions

May 1, 2019

FDA Approves Eticovo (etanercept-ykro), a Biosimilar to Enbrel

Apr 30, 2019

FDA Alert – AmEx Pharmacy Issues Voluntary Nationwide Recall for one Lot of Bevacizumab 1.25mg

Apr 8, 2019

FDA Approves Dovato (dolutegravir/lamivudine) for HIV-1 Infection

Mar 25, 2019

FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Ob

Mar 13, 2019

FDA Approves Rocklatan (netarsudil and latanoprost ophthalmic solution)

Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets

Mar 11, 2019

Apotex Corp. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets

2

3 4

Nurse Talking to Patient

Privacy Policy | Terms & Conditions

Join WhatsApp Broadcast

© Copyright CHEARS®™

Subscribe to Our Newsletter

You are now subscribed to CHEARS

bottom of page